Michael Halpin
Chief Operating Officer at VERICEL CORPORATION
Net worth: 49 367 $ as of 2024-03-30
Michael Halpin active positions
| Companies | Position | Start | End |
|---|---|---|---|
| VERICEL CORPORATION | Chief Operating Officer | 2019-06-14 | - |
| General Counsel | 2017-04-09 | 2019-06-14 |
Career history of Michael Halpin
Former positions of Michael Halpin
| Companies | Position | Start | End |
|---|---|---|---|
Genzyme Corp.
 Genzyme Corp. Medical SpecialtiesHealth Technology Genzyme Corp. engages in development and manufacture of specialty therapeutic, surgical and diagnostic product. It serves in the areas of rare genetic diseases, multiple sclerosis, cardiovascular diseases and endocrinology. The company was founded on June 8, 1981 and is headquartered in Cambridge, MA. | General Counsel | 2002-01-31 | - |
| Corporate Officer/Principal | - | 2017-03-31 | |
| Sanofi Corp. | Corporate Officer/Principal | - | - |
Training of Michael Halpin
| University of Virginia | Graduate Degree |
Statistics
International
| United States | 5 |
Operational
| General Counsel | 2 |
| Corporate Officer/Principal | 2 |
| Chief Operating Officer | 1 |
Sectoral
| Health Technology | 3 |
| Consumer Services | 2 |
Positions held
Active
Inactive
Listed companies
Private companies
Linked companies
| Listed companies | 1 |
|---|---|
| VERICEL CORPORATION | Health Technology |
| Private companies | 2 |
|---|---|
Genzyme Corp.
Genzyme Corp. Medical SpecialtiesHealth Technology Genzyme Corp. engages in development and manufacture of specialty therapeutic, surgical and diagnostic product. It serves in the areas of rare genetic diseases, multiple sclerosis, cardiovascular diseases and endocrinology. The company was founded on June 8, 1981 and is headquartered in Cambridge, MA. | Health Technology |
| Sanofi Corp. |
- Stock Market
- Insiders
- Michael Halpin
- Experience
